As shown in Figure 5, there was a significant association between incidence of IBD-CRC and TP53 mutation among patients with IBD without dysplasia (RR = 5.28; 95% CI: 2.80-10.0, P < 0.001). The gene discussed is TP53; the disease is inflammatory bowel disease.